Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation

Pediatric Dermatology

Volumn 26, Issue 3, 2009, Pages 306-310

  McDermott, David F ^b   Gammon, Bryan ^a   Snijders, Peter J ^c   Mbata, Ihunanya ^b   Phifer, Beth ^d   Howland Hartley, A ^d,e   Lee, Chyi Chia Richard ^a   Murphy, Philip M ^b   Hwang, Sam T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Southern Maryland Skin Specialists   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; GENE PRODUCT; IMIQUIMOD; PROTEIN EVER1; PROTEIN EVER2; UNCLASSIFIED DRUG;

ADULT; ALOPECIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BASAL CELL CARCINOMA; CAFE AU LAIT SPOT; CANCER SURGERY; CASE REPORT; CHILD; CRYOTHERAPY; DRUG TREATMENT FAILURE; EPIDERMODYSPLASIA VERRUCIFORMIS; FATHER; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; MALE; NONSENSE MUTATION; OPEN READING FRAME; PEDIGREE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN BIOPSY; SKIN EXAMINATION; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; ULTRAVIOLET RADIATION; VERRUCA VULGARIS; WART VIRUS;

ADULT; CHILD; CODON, NONSENSE; EPIDERMODYSPLASIA VERRUCIFORMIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; PAPILLOMAVIRUS INFECTIONS;

EID: 67650491404     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00853.x     Document Type: Article

References (19)

1. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006 18 : 362 374. (Pubitemid 44511885)
2. Jablonska S, Orth G. Epidermodysplasia verruciformis. Clin Dermatol 1985 3 : 83 96.
3. Nuovo GJ, Ishag M. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol 2000 24 : 1400 1406. (Pubitemid 30764407)
4. Brink AA, Lloveras B, Nindl I et al. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 2005 43 : 5581 5587. (Pubitemid 41612334)
5. Sun XK, Chen JF, Xu AE. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 2005 30 : 573 574.
6. Androphy EJ, Dvoretzky I, Maluish AE et al. Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol 1984 11 : 197 202. (Pubitemid 14096787)
7. Gross G, Ellinger K, Roussaki A et al. Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 1988 91 : 43 48. (Pubitemid 18155390)
8. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984 83 : 18s 25s. (Pubitemid 14088892)
9. Hu W, Nuovo G, Willen M et al. Epidermodysplasia verruciformis in two half brothers with HIV infection. J Cutan Med Surg 2004 8 : 357 360. (Pubitemid 41542425)
10. Anadolu R, Oskay T, Erdem C et al. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol 2001 45 : 296 299. (Pubitemid 32729317)
11. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer 1978 65 : 169 182.
12. Ramoz N, Taieb A, Rueda LA et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000 114 : 1148 1153. (Pubitemid 30415231)
13. Ramoz N, Rueda LA, Bouadjar B et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002 32 : 579 581. (Pubitemid 35435168)
14. Tate G, Suzuki T, Kishimoto K et al. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004 49 : 223 225. (Pubitemid 38657572)
15. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol 1985 121 : 864 868. (Pubitemid 15070196)
16. Akgul B, Kose O, Safali M et al. A distinct variant of epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci 2007 46 : 214 216. (Pubitemid 46601835)
17. Azzimonti B, Mondini M, De Andrea M et al. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol 2005 141 : 1323 1325. (Pubitemid 41498940)
18. Kurima K, Peters LM, Yang Y et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 2002 30 : 277 284. (Pubitemid 34887685)
19. Vreugde S, Erven A, Kros CJ et al. Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat Genet 2002 30 : 257 258. (Pubitemid 34887682)